Medprime Technologies, a medical device company based in Thane, announced the launch of Micalys, an innovative digital microscopy platform integrated with artificial intelligence (AI). This cutting-edge technology is poised to transform digital pathology in India.
Micalys is anticipated to become a crucial asset in diagnostic laboratories, research centers, and educational institutions across India. It will be valuable for both pathologists and patients, regardless of their socio-economic status.
The global shortage of pathologists, coupled with the growing patient numbers and preventive testing needs, has placed significant pressure on practicing pathologists. Most experts are concentrated in Tier 1 cities, which increases the need for transporting samples from rural and smaller urban areas to larger cities. Micalys addresses this issue by enabling remote diagnosis, allowing a doctor anywhere in the world to confidently analyze cases without being physically present in the lab.
As reported by biospectrumindia.com, Micalys also holds great promise for screening malaria, filaria, and tuberculosis in resource-limited settings. Machine learning-based analysis algorithms can assist in diagnosing these infections even in the absence of trained technicians, thus filling a critical gap in the current diagnostic framework.